busulfan has been researched along with Digestive System Disorders in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Busulfan is a major component of chemotherapy conditioning in hematopoietic cell transplantation (HCT)." | 5.51 | Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient. ( Bezinelli, LM; Carvalho, DLC; Corrêa, L; da Silva, CC; Eduardo, FP; Ferreira, MH; Gobbi, M; Hamerschlak, N; Rosin, FCP, 2019) |
"Busulfan is a major component of chemotherapy conditioning in hematopoietic cell transplantation (HCT)." | 1.51 | Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient. ( Bezinelli, LM; Carvalho, DLC; Corrêa, L; da Silva, CC; Eduardo, FP; Ferreira, MH; Gobbi, M; Hamerschlak, N; Rosin, FCP, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eduardo, FP | 1 |
Bezinelli, LM | 1 |
Gobbi, M | 1 |
Rosin, FCP | 1 |
Carvalho, DLC | 1 |
Ferreira, MH | 1 |
da Silva, CC | 1 |
Hamerschlak, N | 1 |
Corrêa, L | 1 |
Baronciani, D | 1 |
Rambaldi, A | 1 |
Iori, AP | 1 |
Di Bartolomeo, P | 1 |
Pilo, F | 1 |
Pettinau, M | 1 |
Depau, C | 1 |
Mico, C | 1 |
Santarone, S | 1 |
Angelucci, E | 1 |
1 trial available for busulfan and Digestive System Disorders
Article | Year |
---|---|
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients.
Topics: Adolescent; Adult; Aged; Busulfan; Chemical and Drug Induced Liver Injury; Combined Modality Therapy | 2008 |
1 other study available for busulfan and Digestive System Disorders
Article | Year |
---|---|
Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient.
Topics: Adult; Aged; Busulfan; Digestive System Diseases; Female; Graft vs Host Disease; Hematopoietic Stem | 2019 |